Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin.
Domenica Mangieri,Beatrice Nico,Vincenzo Benagiano,Michela De Giorgis,Angelo Vacca,Domenico Ribatti +5 more
TL;DR: Data suggest that angiogenic switch in MM may involve loss of an endogenous angiogenesis inhibitor, such as endostatin.
30
Vascular co-option and vasculogenic mimicry mediate resistance to antiangiogenic strategies
Francesco Pezzella,Domenico Ribatti +1 more
- 09 Dec 2020
TL;DR: The discovery that vascular co-opting and vasculogenic mimicry are two ways of escaping antiangiogenic treatment, prompts the need for a better understanding of this phenomenon in order to improve cancer treatment.
30
Miller's seminal studies on the role of thymus in immunity.
TL;DR: This review article summarizes the seminal work of the Australian scientist Francis Albert Pierre Miller concerning the description for the first time of the crucial role of the thymus for normal development of the immune system.
30
•Journal Article
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
TL;DR: In this paper, the role of coated cationic liposomes (CCL) treatment in the susceptibility to doxorubicin (DXR) in human melanoma cells, both in vitro and in vivo, was defined.
30
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?
Ilaria Saltarella,Maria Antonia Frassanito,Aurelia Lamanuzzi,Arianna Brevi,Patrizia Leone,Vanessa Desantis,Lucia Di Marzo,Matteo Bellone,Daniele Derudas,Domenico Ribatti,Raffaella Chiaramonte,M.T. Palano,Antonino Neri,Maria Addolorata Mariggiò,Ruggiero Fumarulo,Franco Dammacco,Vito Racanelli,Angelo Vacca,Roberto Ria +18 more
TL;DR: Overall, homotypic and heterotypic Jagged1/2-mediated Notch activation enhances MMECs angiogenesis, suggesting that the Notch pathway may represent a novel therapeutic target in MM.
30